Regeneron Pharmaceuticals (REGN.MX) Q1 2026 Earnings

Jan 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
158.89
186.9
214.91
242.93

Details

Expected EPS
187.36760650899998
Actual EPS
199.66232
Surprise EPS
12.29
Surprise Percent
+6.56%

Description

⁨Regeneron Pharmaceuticals⁩ (⁦REGN.MX⁩) has reported earnings of ⁦199.66232⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts